Pharmaceuticals, Biotechnology and Life Sciences
The U.S. Food and Drug Administration has approved Mylan’s Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta (pegfilgrastim) to decrease the chance…
Bayer plans to complete the acquisition of Monsanto on June, 7, doubling the size of its agriculture business, the company…
Novartis on Sunday announced positive results from the third Phase III trial of Kisqali in advanced or metastatic breast cancer.
FibroGen, a biopharmaceutical company, on Monday said the results from the Phase 1/2 clinical trial, testing pamrevlumab in combination with…
Celgene Corporation’s study testing Revlimid on patients with previously untreated follicular lymphoma showed that treatment with a chemotherapy-free R2 regimen offered numerically…
Celgene Corporation has hired David V. Elkins as Executive Vice President (EVP), Chief Financial Officer (CFO), who will join the…
Sandoz said Friday that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has…
Bavarian Nordic has appointed new Chief Financial Officer, coming from a Nasdaq Stockholm exchange listed pharmaceutical company, Orexo AB, it said…
Arix Bioscience’s Non-Executive Director Lord Hutton is stepping down from his position, Arix said Thursday.
Boehringer Ingelheim’s study showed that dose adjustment with Gilotrif helped improve patient tolerability while maintaining treatment efficacy and reduced the frequency…